Wird geladen...
The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
BACKGROUND & AIMS: It is unknown whether the addition of locoregional therapies (LRTx) to sorafenib improves prognosis over sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). The aim of this study was to assess the effect of LRTx in this population. METHODS: A retrospectiv...
Gespeichert in:
Veröffentlicht in: | HPB (Oxford) |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Elsevier
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4857060/ https://ncbi.nlm.nih.gov/pubmed/27154804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2016.02.007 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|